Discovery Grants are one-year, $50,000 grants for high risk, high impact research with the potential to change current diagnostic or treatment models. Grants are intended to provide seed-funding for early-stage faculty-level researchers to develop their new ideas, and to get the preliminary data needed to apply for larger grants.
Applicant/Principal Investigator (PI) Requirements:
• At the time of LOI submission applicants MUST
o Have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent.
o Hold a full-time faculty position and cannot have held a full-time faculty
appointment before September 1, 2018. A documented leave of absence may be
excluded from the eight-year window of eligibility, such as for parental leave or
other well justified leave from research, of generally less than 12-months
duration.
Applicants whose experience exceeds the maximum of eight years but who
believe they are eligible must email ABTA at grants@abta.org with their
biosketch and a description of how the leave of absence will be documented
within the application before submitting their application to verify their eligibility.
• Is not required to be a U.S. citizen or resident.
• May only submit ONE Discovery Grant Letter of Intent per funding cycle.
• May not be a PI on another ABTA grant at the start of the grant term.
Lead Mentor Requirements:
A Lead Mentor is required for Applicants/PIs that are within the first five years of their first
faculty appointment (i.e., started their first faculty position after December 31, 2020); optional for
Applicants/PIs beyond five years of a faculty appointment.
• Must hold a full-time faculty appointment at the same institution as the Applicant/PI.
• Must currently conduct brain tumor research.
• Is not required to be a U.S. citizen or resident.
• Can be a mentor on more than one 2026 Discovery Grant Application.
Lead Institution Requirements:
• Must be a non-profit institution or organization anywhere in the world.
• Must not be a governmental institution (i.e. NIH, NCI, etc.).
• Must serve as the administrator of the grant funds and will hold responsibility for the
management of the budget and submission of all required documents and reports.
Sponsor Institute/Organizations: American Brain Tumor Association
Sponsor Type: Corporate/Non-Profit
Address: 8550 W. Bryn Mawr Ave. Ste 550 Chicago, IL 60631
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 10, 2025
Mar 30, 2026
$50,000
Affiliation: American Brain Tumor Association
Address: 8550 W. Bryn Mawr Ave. Ste 550 Chicago, IL 60631
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.